{{Rsnum
|rsid=80356615
|Chromosome=11
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=KCNJ11
|position=17387934
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=KCNJ11
}}{{omim
|id=600937
|rsnum=80356615
|variant=0021
}}{{ClinVar
|rsid=80356615
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=17409481
|CHROM=11
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050368000000000002110100
|GENEINFO=KCNJ11:3767
|GENE_NAME=KCNJ11
|GENE_ID=3767
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.17409481C>T
|CLNSRC=GeneReviews; OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=NBK1447; 600937.0021
|CLNSIG=5
|CLNCUI=C1833104
|CLNDBN=Diabetes mellitus, permanent neonatal, with neurologic features; Permanent neonatal diabetes mellitus
|Disease=Diabetes mellitus; Permanent neonatal diabetes mellitus
|CLNACC=RCV000009222.1; RCV000020349.1
|Tags=RV;PM;PMC;S3D;SLO;OTHERKG;LSD;OM
|CLNDSDB=MedGen; GeneReviews:MedGen:OMIM:Orphanet:Orphanet
|CLNDSDBID=C1833102; NBK1447:C1833104:606176:79134:99885
}}{{PMID Auto
|PMID=18073297
|Title=The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.
|OA=1
}}